Article Text

other Versions

PDF
Total cholesterol and LDL levels decrease before rheumatoid arthritis
  1. Elena Myasoedova,
  2. Cynthia S Crowson,
  3. Hilal Maradit-Kremers,
  4. Patrick D J Fitz-Gibbon,
  5. Terry M Therneau,
  6. Sherine E Gabriel*
  1. Mayo Clinic, United States
  1. Correspondence to: Sherine E Gabriel, Health Sciences Research, Mayo Clinic, Dept of Health Sciences Research, 200 First St . SW, Rochester, 55905, United States; gabriel.sherine{at}mayo.edu

Abstract

Objectives: To compare lipid profiles in patients with rheumatoid arthritis (RA) and non-RA subjects during the 5 years before and 5 years after RA incidence/index date.

Methods: Lipid measures were abstracted in a population-based incident cohort of RA patients (1987 ACR criteria) first diagnosed between 1/1/1988 and 1/1/2008 and in non-RA subjects. Random effects models adjusting for age, sex and calendar year were used to examine trends in lipid profiles, accounting for multiple measurements per subject.

Results: Study population included a cohort of 577 RA patients (a total of 3,088 lipid measurements) and 540 non-RA subjects (a total of 3,048 lipid measurements). There were significant decreases in total [TCh] and low-density cholesterol [LDL] levels in the RA cohort during the 5 years before RA, compared to the non-RA cohort (p<0.001). Trends in other lipid measures (triglycerides and high-density cholesterol) were similar in RA and non-RA cohorts during the 5 years before and 5 years after RA incidence/index date. During the 5 years before RA incidence/index date, the proportion of RA patients with elevated TCh or LDL measures, but not with abnormal HDL and TG measures, significantly decreased compared to non-RA subjects. Lipid-lowering drugs (statins in particular) were less often (p=0.02) prescribed to RA patients than to non-RA subjects.

Conclusion: TCh and LDL levels and the prevalence of abnormal TCh or LDL measures decreased significantly during the 5 years before RA incidence/index date in RA patients as compared to non-RA cohort. These trends in lipid profile in RA are unlikely to be solely due to lipid-lowering therapy.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.